Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
more
I am looking for
added new label for I am looking for
more
Advanced Filters
Found 104 clinical trials
Nab-paclitaxel Compared With Docetaxel Followed by Anthracyclines and Cyclophosphamide in the Neoadjuvant Breast Cancer

this study is to evaluate the efficacy of dose-dense nab-paclitaxel compared with dose-dense docetaxel followed by anthracycline and cyclophosphamide in the treatment of HR positive and HER-2 negative

mammogram
paclitaxel
erbb2
anthracyclines
invasive breast cancer
  • 1 views
  • 23 Jan, 2021
  • 1 location
The TP Regimen in the Treatment of Early Triple Negative Breast Cancer

compare the efficacy of TP and EC-T / TEC regimen in the neoadjuvant chemotherapy of TNBC. Besides, the application of anthracycline drugs is limited to a certain extent due to the cardiotoxicity. Based

  • 0 views
  • 26 Jan, 2021
  • 1 location
Remote Ischaemic Preconditioning in Childhood Cancer

inflation and deflation of blood pressure cuff placed over the arm or leg to induce limb ischaemia and reperfusion injury. It is noteworthy that anthracycline cardiotoxicity and myocardial reperfusion

childhood cancer
troponin
metastasis
cancer
dexrazoxane
  • 0 views
  • 07 May, 2021
  • 2 locations
IA14 Induction in Young Acute Myeloid Leukemia

with cytarabine and daunorubicin/Idarubicin, typically called "7+3", has not changed for several decades, the best dosage of anthracycline is still unknown. Several prospective trials have demonstrated

cytarabine
idarubicin
daunorubicin
cell transplantation
cytarabine/daunorubicin
  • 0 views
  • 15 Jun, 2021
  • 1 location
Efficacy of the Combination of Nivolumab and Ipilimumab as a Treatment in Patients With Sarcoma of Rare Subtype

This is a randomized open label study, with 2 arms treatments conducted in patients with metastatic or unresectable advanced sarcoma of rare subtype; previously treated by anthracycline-based

  • 0 views
  • 26 Apr, 2021
  • 1 location
PG2 Treatment Among Stage II/III Breast Cancer Patients Receiving Adjuvant Chemotherapy

of breast cancer recurrence. Anthracycline-based regimens, including doxorubin or epilubicin, are the breast cancer adjuvant chemotherapy standards of care. Fatigue has also been identified as the

  • 4 views
  • 09 Apr, 2021
  • 5 locations
PETHEMA-LMA10: Treatment of Acute Myeloblastic Leukemia (AML) in Patients Less Than or Equal to 65 Years

same. While there is broad agreement in terms of induction chemotherapy using a combination of cytarabine with anthracycline, the choice of chemotherapy regimen is controversial postremisin

minimal residual disease
acute promyelocytic leukemia
flow cytometry
induction chemotherapy
cytarabine
  • 12 views
  • 29 Mar, 2021
  • 1 location
Anlotinib Combined With Dose-dense Temozolomide for the First Recurrent or Progressive Glioblastoma After STUPP Regimen

be safe and effective in advanced lung cancer(including NSCLC,SCLC)after second-line standard chemotherapy failure,and advanced soft tissue sarcoma after anthracycline-containing chemotherapy

tyrosine
supratentorial glioblastoma multiforme
aptt
complete resection
cancer
  • 0 views
  • 25 Jan, 2021
  • 1 location
Prevention of Cardiac Dysfunction During Breast Cancer Therapy

trial we hypothesize that sacubitril/valsartan used concomitantly during anthracycline containing chemotherapy for breast cancer treatment prevents cardiac dysfunction as measured by cardiac magnetic

valsartan
heart failure
enalapril
angiotensin
MRI
  • 0 views
  • 22 Aug, 2021
  • 4 locations
Cancer Adverse Effects PReventIon With Care & Exercise: the CAPRICE Study

improvements in cancer-free survival have been achieved in the last decades, the development of cardiac toxicity, associated with anthracycline-based chemotherapy (Anth-bC) counteracts the improvements in

hodgkin's disease
depressive symptoms
troponin
fatigue
strain
  • 5 views
  • 16 May, 2021
  • 5 locations